Loading market dashboard
CymaBay Therapeutics, Inc.
CBAYHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
CymaBay Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $695.08M | $695.08M - $695.08M | $417.05M | $2.645 | 4 |
| Dec 2027 | $457.11M | $457.11M - $457.11M | $274.27M | $1.268 | 3 |
| Dec 2026 | $269.77M | $267.61M - $271.92M | $161.86M | -$0.064 | 7 |
| Dec 2025 | $109.63M | $12.29M - $267.18M | $65.78M | -$1.032 | 5 |
| Dec 2024 | $12.35M | $4.37M - $21.72M | $7.41M | -$1.378 | 3 |
| Dec 2023 | $31.31M | $31.27M - $31.68M | $18.79M | -$0.944 | 10 |
| Dec 2021 | $6.43M | $1.06M - $13.99M | $3.86M | -$1.134 | 6 |
| Dec 2017 | $6.25M | $1.03M - $13.61M | $3.75M | -$0.898 | 6 |